Molecular genetics and pathogenesis of autosomal dominant polycystic kidney disease

Annual Review of Medicine

Volumn 52, Issue , 2001, Pages 93-123

  Arnaout, M A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adherens junctions; Cell polarity; Polycystic kidneys; Polycystins; Vascular aneurysms

Indexed keywords

ION CHANNEL; POLYCYSTIN;

ANEURYSM; AUTOSOMAL DOMINANT DISORDER; CELL ADHESION; CELL POLARITY; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GENE MUTATION; HUMAN; KIDNEY POLYCYSTIC DISEASE; MOLECULAR GENETICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; GENE FREQUENCY; HUMANS; MEMBRANE PROTEINS; MICE; MODELS, GENETIC; MOLECULAR BIOLOGY; MUTATION; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PROTEINS; TRPP CATION CHANNELS;

EID: 0035127256     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.52.1.93     Document Type: Review

References (227)

1. Fluid secretion, cellular proliferation, and the pathogenesis of renal epithelial cysts
2. Autosomal dominant polycystic kidney disease
3. Polycystic kidney disease: Hereditary and acquired
4. Hypertension in autosomal dominant polycystic kidney disease
5. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980
6. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease
7. Familial phenotype differences in PKD11
8. Characteristics of very early onset autosomal dominant polycystic kidney disease
9. Value of magnetic resonance angiography for the detection of intracranial aneurysms in autosomal dominant polycystic kidney disease
10. Occult intracranial aneurysms in polycystic kidney disease: Screening with MR angiography
11. Extrarenal manifestations of ADPKD
12. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease
13. Is gender a determinant for evolution of renal failure? A study in autosomal dominant polycystic kidney disease
14. Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease
15. Hereditary polycystic kidney disease (adult form): Amicrodissection study of two cases at an early stage of the disease
16. Glomerulocystic kidney disease - Nosological considerations
17. Cyst formation and growth in autosomal dominant polycystic kidney disease
18. Pathogenesis of polycystic kidney disease: Altered cellular function
19. Macropuncture study of polycystic disease in adult human kidneys
20. Renal excretion and cyst accumulation of beta 2 microglobulin in polycystic kidney disease
21. Matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases expression by tubular epithelia and interstitial fibroblasts in the normal kidney and in fibrosis
22. Cytokines in fluids from polycystic kidneys
23. Ultrastructure and function of cysts from human adult polycystic kidneys
24. Potential causes and pathogenesis in autosomal dominant polycystic kidney disease
25. Renal histology in polycystic kidney disease with incipient and advanced renal failure
26. The anatomy of the renin-secreting cell in adult polycystic kidney disease
27. Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease
28. Renal endothelin system in polycystic kidney disease
29. Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease
30. Autosomal dominant polycystic kidney disease (ADPKD - Mechanisms of cyst formation and renal failure
31. Erythropoietin in polycystic kidneys
32. Intracranial aneurysms in autosomal dominant polycystic kidney disease
33. Intracranial aneurysms in autosomal dominant polycystic kidney disease
34. Intracranial arterial dolichoectasia in autosomal dominant polycystic kidney disease
35. Cardiovascular abnormalities associated with adult polycystic kidney disease
36. Autosomal dominant polycystic kidney disease
37. Autosomal dominant polycystic kidney disease in a kidney transplant population
38. A kindred exhibiting cosegregation of an overlap connective tissue disorder and the chromosome 16 linked form of autosomal dominant polycystic kidney disease
39. Intracranial dissecting and saccular aneurysms in polycystic kidney disease
40. Thoracic aortic dissection complicating autosomal dominant polycystic kidney disease
41. Aneurysm of the splenic artery in a patient with autosomal dominant polycystic kidney disease
42. Echocardiographic findings in autosomal dominant polycystic kidney disease
43. The spectrum of cardiovascular abnormalities in autosomal dominant polycystic kidney disease: A 10-year follow-up in a five-generation kindred
44. Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease
45. Left ventricular mass in normotensive subjects with autosomal dominant polycystic kidney disease
46. Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease
47. Spontaneous artery dissection: Is it part of the spectrum of autosomal dominant polycystic kidney disease?
48. Causes of death in autosomal dominant polycystic kidney disease
49. Recurrent rupture of intracranial aneurysms in autosomal dominant polycystic kidney disease
50. Cardiovascular mortality of patients with polycystic kidney disease on dialysis: Is there a lesson to learn?
51. Long-term cardiovascular morbidity and mortality in autosomal dominant polycystic kidney disease patients after renal transplantation
52. Kinetics of cyst development in cystic renal disease
53. Adult polycystic disease
54. Polypoid and papillary epithelial hyperplasia: A potential cause of ductal obstruction in adult polycystic disease
55. Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation
56. Somatic inactivation of Pkd2 results in polycystic kidney disease
57. Polycystin 1 is required for the structural integrity of blood vessels
58. Pathogenesis of polycystic kidneys
59. Polycystic kidney disease: A predominance of giant nephrons
60. Tubular basement membrane change occurs pad passu with the development of cyst formation
61. Basement membrane alterations during development and regression of tubular cysts
62. Altered basement membrane protein biosynthesis by primary cultures of cpk/cpk mouse kidney
63. Basement membrane antigens in renal polycystic disease
64. Decreased synthesis and delayed processing of sulfated glycoproteins by cells from human polycystic kidneys
65. Impaired tubulogenesis of cyst-derived cells from autosomal dominant polycystic kidneys
66. Biology of polycystic kidney disease
67. A new method for studying human polycystic kidney disease epithelia in culture
68. Proliferative activity of cyst epithelium in human renal cystic diseases
69. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD)
70. Cyst-derived cells do not exhibit accelerated growth or features of transformed cells in vitro
71. Increased epithelial cell proliferation and abnormal extracellular matrix in rat polycystic kidney disease
72. Elevated proto-oncogene expression in polycystic kidneys of the C57BL/6J (cpk) mouse
73. c-myc as an inducer of polycystic kidney disease in transgenic mice
74. Renal cysts in transgenic mice expressing transforming growth factoralpha
75. Renal cyst formation and multifocal neoplasia in transgenic mice carrying the simian virus 40 early region
76. An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice
77. Cystic kidneys: An enigma evolves
78. Apoptosis and loss of renal tissue in polycystic kidney diseases
79. Function of the c-Myc oncogenic transcription factor
80. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
81. c-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent
82. The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease
83. In situ studies of the distal convoluted tubule in the rat. I. Evidence for NaCl secretion
84. Secretion of salt and water into the medullary collecting duct of Ringer-infused rats
85. Crypt base cells show forskolin-induced C1 secretion but no cation inward conductance
86. Significance of ion transport during lung development and in respiratory disease of the newborn
87. In vitro fluid secretion by epithelium from polycystic kidneys
88. Epithelial transport in polycystic kidney disease
89. Chloride and fluid secretion by cultured human polycystic kidney cells
90. Immunolocalization of ion transport proteins in human autosomal dominant polycystic kidney epithelial cells
91. Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease
92. +-ATPase: Mislocation to apical plasma membranes in polycystic kidney disease epithelia
93. Abnormal sodium pump distribution during renal tubulogenesis in congenital murine polycystic kidney disease
94. Cell polarity in human renal cystic disease
95. Pax2 in development and renal disease
96. Expression of differentiation antigens and growth-related genes in normal kidney, autosomal dominant polycystic kidney disease, and renal cell carcinoma
97. The SGP-2 gene is developmentally regulated in the mouse kidney and abnormally expressed in collecting duct cysts in polycystic kidney disease
98. Expression of clusterin in human renal diseases
99. The pathogenesis of polycystic kidney disease
100. Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD
101. Renal epithelial cell secretion and cell growth: The role of cyclic AMP
102. Developmentally regulated conversion of mesenchyme to epithelium
103. Coexpression of extracellular matrix glycoproteins undulin and tenascin in human autosomal dominant polycystic kidney disease
104. A highly polymorphic DNA marker linked to adult polcystic kidney disease on chromosome 16
105. Icelandic families with autosomal dominant polycystic kidney disease: Families unlinked to chromosome 16p13.3 revealed by linkage analysis
106. Autosomal dominant polycystic kidney disease: Localization of the second gene to chromosome 4q13-q23
107. Identification and characterization of the tuberous sclerosis gene on chromosome 16. The European Chromosome 16 Tuberous Sclerosis Consortium
108. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16
109. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein
110. Evidence for a third genetic locus for autosomal dominant polycystic kidney disease
111. An Italian family with autosomal dominant polycystic kidney disease unlinked to either the PKD1 or PKD2 gene
112. A family with a milder form of adult dominant polycystic kidney disease not linked to the PKD1 (16p) or PKD2 (4q) genes
113. Is there a third gene for autosomal dominant polycystic kidney disease?
114. Polycystin-1 expression in PKD1, early-onset PKD1, and TSC2/PKD1 cystic tissue
115. A de novo pathological point mutation at the 21-hydroxylase locus: Implications for gene conversion in the human genome
116. Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequence
117. Identification and characterization of NF1-related loci on human chromosomes 22, 14 and 2
118. The signature of somatic hypermutation appears to be written into the germline IgV segment repertoire
119. Gene conversion is a likely cause of mutation in PKD1
120. DNA structural transitions within the PKD1 gene
121. Mutagenesis in mammalian cells induced by triple helix formation and transcription-coupled repair
122. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I
123. The mouse homologue of the polycystic kidney disease gene (Pkd1) is a single-copy gene
124. Murine Pkd1 introns 21 and 22 lack the extreme polypyrimidine bias present in human PKD1
125. Identification of mutations in the duplicated region of the polycystic kidney disease 1 gene (PKD1) by a novel approach
126. Somatic mutations are frequent and increase with age in human kidney epithelial cells
127. Characterization of the exon structure of the polycystic kidney disease 2 gene (PKD2)
128. Molecular cloning, cDNA sequence analysis, and chromosomal localization of mouse Pkd2
129. Polycystic kidney disease: The complete structure of the PKD1 gene and its protein
130. A latrophilin/CL-1-like GPS domain in polycystin-1
131. The PLAT domain: A new piece in the PKD1 puzzle
132. Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains
133. Structural diversity of cell adhesion molecules and their role in inflammation
134. Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module
135. The structure of a PKD domain from polycystin-1: Implications for polycystic kidney disease
136. The sea urchin sperm receptor for egg jelly is a modular protein with extensive homology to the human polycystic kidney disease protein, PKD1
137. The fucose sulfate polymer of egg jelly binds to sperm REJ and is the inducer of the sea urchin sperm acrosome reaction
138. Structure and function of voltage-sensitive ion channels
139. Capacitative calcium entry channels
140. Specific association of the gene product of PKD2 with the TRPC1 channel
141. Identification and characterization of polycystin-2, the PKD2 gene product
142. PKD1 interacts with PKD2 through a probable coiled-coil domain
143. The polycystic kidney disease protein PKD2 interacts with hax-1, a protein associated with the actin cytoskeleton
144. Identification of PKDL, a novel polycystic kidney disease 2-like gene whose murine homologue is deleted in mice with kidney and retinal defects
145. Identification of PKD2L, a human PKD2-related gene: Tissue-specific expression and mapping to chromosome 10q25
146. The human polycystic kidney disease 2-like (PKDL) gene: Exon/intron structure and evidence for a novel splicing mechanism
147. Polycystin-L is a calcium-regulated cation channel permeable to calcium ions
148. Identification of a human homologue of the sea urchin receptor for egg jelly: A polycystic kidney disease-like protein
149. Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2)
150. Murine Pkd1 is a developmentally regulated gene from morula to adulthood: Role in tissue condensation and patterning
151. Immunolocalization of polycystin in human tissues and cultured cells
152. Characterization and cell distribution of polycystin, the product of autosomal dominant polycystic kidney disease gene 1
153. Adult, fetal, and polycystic kidney expression of polycystin, the polycystic kidney disease-1 gene product
154. Identification and localization of polycystin, the PKD1 gene product
155. Distribution and developmentally regulated expression of murine polycystin
156. Polycystin expression is temporally and spatially regulated during renal development
157. Polycystin: In vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein
158. Polycystin expression during embryonic development of human kidney in adult tissues and ADPKD tissue
159. Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue
160. Characterization and expression of the PKD-1 protein, polycystin, in renal and extrarenal tissues
161. Cellular localization and tissue distribution of polycystin-1
162. Vascular expression of polycystin
163. Expression of polycystin in mouse metanephros and extra-metanephric tissues
164. K562 erythroid and HL60 macrophage differentiation downregulates polycystin, a large membrane-associated protein
165. Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney
166. Cellular and subcellular distribution of polycystin-2, the protein product of the PKD2 gene
167. Colocalization of the polycystin kidney gene product PKD 1 with the tight junction protein ZO-1 in normal and ischemic rat proximal tubules
168. A polycystic kidney-disease gene homologue required for male mating behaviour in C. elegans
169. Plugging the leaks
170. Molecular architecture of tight junctions
171. Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins
172. The PKD1 gene product, "polycystin-1," is a tyrosinephosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal epithelia
173. Morphogenetic mechanisms of epithelial tubulogenesis: MDCK cell polarity is transiently rearranged without loss of cell-cell contact during scatter factor/hepatocyte growth factor-induced tubulogenesis
174. Genetic evidence for a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease
175. A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2)
176. A translation frameshift mutation induced by a cytosine insertion in the polycystic kidney disease 2 gene (PDK2)
177. Novel stop and frameshifting mutations in the autosomal dominant polycystic kidney disease 2 (PKD2) gene
178. A spectrum of mutations in the polycystic kidney disease-2 (PKD2) gene from eight Canadian kindreds
179. A novel frameshift mutation induced by an adenosine insertion in the polycystic kidney disease 2 (PKD2) gene
180. Mutations in autosomal dominant polycystic kidney disease 2 gene: Reduced expression of PKD2 protein in lymphoblastoid cells
181. Aberrant splicing in the PKD2 gene as a cause of polycystic kidney disease
182. Seven novel mutations of the PKD2 gene in families with autosomal dominant polycystic kidney disease
183. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16
184. Splicing mutations of the polycystic kidney disease 1 (PKD 1) gene induced by intronic deletion
185. Detection of a novel nonsense mutation and an intragenic polymorphism in the PKD1 gene of a Cypriot family with autosomal dominant polycystic kidney disease
186. Screening the 3′ region of the polycystic kidney disease 1 (PKD1) gene reveals six novel mutations
187. A stable, nonsense mutation associated with a case of infantile onset polycystic kidney disease 1 (PKD1)
188. Autosomal dominant polycystic kidney disease (ADPKD) in an Italian family carrying a novel nonsense mutation and two missense changes in exons 44 and 45 of the PKD1 gene
189. Detection of two different nonsense mutations in exon 44 of the PKD1 gene in two unrelated Italian families with severe autosomal dominant polycystic kidney disease
190. Novel and recurrent mutations in the PKD1 (polycystic kidney disease) gene
191. Recurrence of the PKD1 nonsense mutation Q4041X in Spanish, Italian, and British families
192. Mutational analysis within the 3′ region of the PKD1 gene
193. An unusual pattern of mutation in the duplicated portion of PKD1 is revealed by use of a novel strategy for mutation detection
194. Loss of heterozygosity in polycystic kidney disease with a missense mutation in the repeated region of PKD1
195. Identification of mutations in the repeated part of the autosomal dominant polycystic kidney disease type 1 gene, PKD1, by long-range PCR
196. Mutation detection of PKD1 identifies a novel mutation common to three families with aneurysms and/or very-early-onset disease
197. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease - A contiguous gene syndrome
198. Facilitated diagnosis of the contiguous gene syndrome: Tuberous sclerosis and polycystic kidneys by means of haplotype studies
199. Gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle
200. Defective epidermal growth factor gene expression in mice with polycystic kidney disease
201. Epidermal growth factor (EGF) expression in the congenital polycystic mouse kidney
202. Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease
203. Glomerulosclerosis and renal cysts in mice transgenic for the early region of SV40
204. Targeted disruption of Bcl-2 alpha beta in mice: Occurrence of gray hair, polycystic kidney disease, and lymphocytopenia
205. Loss of function as a mechanism for cystogenesis in mice with PKD1 null mutation
206. Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes
207. Nephrology forums: Pathogenesis of the vasculopathy of autosomal dominant polycystic kidney disease: Insights from animal models
208. Cardiac defects and renal failure in mice with targeted mutations in Pkd2
209. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1
210. Identification of an essential nonneuronal function of neurotrophin 3 in mammalian cardiac development
211. RXR alpha deficiency confers genetic susceptibility for aortic sac, conotruncal, atrioventricular cushion, and ventricular muscle defects in mice
212. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1
213. Development of a lethal congenital heart defect in the splotch (Pax3) mutant mouse
214. Nonmuscle myosin II-B is required for normal development of the mouse heart
215. A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype
216. Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis
217. Somatic mutation in individual liver cysts supports a two-hit model of cystogenesis in autosomal dominant polycystic kidney disease
218. Normal colonic mucosa in hereditary non-polyposis colorectal cancer shows no generalised increase in somatic mutation
219. Impact of age and environment on somatic mutation at the hprt gene of T lymphocytes in humans
220. The discs-large tumor suppressor gene of Drosophila encodes a guanylate kinase homolog localized at septate junctions
221. The C. elegans vulval induction gene lin-2 encodes a member of the MAGUK family of cell junction proteins
222. New perspectives on mechanisms involved in generating epithelial cell polarity
223. Sec6/8 complex is recruited to cell-cell contacts and specifies transport vesicle delivery to the basallateral membrane in epithelial cells
224. Protein trafficking and polarity in kidney epithelium: From cell biology to physiology
225. Progressive kidney degeneration in mice lacking tensin
226. Progress in blood pressure control in autosomal dominant polycystic kidney disease
227. Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor